Amphastar Pharmaceuticals Inc.

AMPH | NASDAQ

$24.76

+$0.28 (+1.14%)

Sep 22, 2026, 1:07 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	719.89M	731.97M	644.4M	498.99M	437.77M	349.85M
Cost of Revenue	363.83M	358.11M	293.27M	250.13M	238.03M	206.51M
Gross Profit	356.06M	373.86M	351.12M	248.86M	199.74M	143.34M
Operating Income	140.4M	205.42M	196.99M	107.5M	69.89M	10.95M
Interest Income	8.68M	10.61M	5.46M	1.32M	601K	642K
Pretax Income	123.62M	189.19M	169.38M	114.86M	83.93M	4.64M
Net Income	98.09M	159.52M	137.55M	91.39M	62.12M	1.4M
Selling & General & Admin	129.81M	94.52M	80.39M	66.59M	68.92M	65.16M
Research & Development	85.84M	73.91M	73.74M	74.77M	60.93M	67.23M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	215.65M	168.44M	154.13M	141.36M	129.85M	132.39M
Interest Expense	25.48M	30.34M	27.16M	1.85M	885K	374K
Selling & Marketing Expenses	43.89M	37.8M	28.85M	21.53M	17.49M	14.78M
Cost & Expenses	579.48M	526.55M	447.41M	391.49M	367.88M	338.89M
Income Tax Expense	25.53M	29.67M	31.83M	23.48M	20.63M	3.54M
Shares Outstanding (Basic)	46.74M	48.43M	48.27M	48.55M	47.78M	47.04M
Shares Outstanding (Diluted)	48.22M	52.06M	53M	52.43M	49.78M	49.12M
EPS (Basic)	2.10	3.29	2.85	1.88	1.30	0.03
EPS (Diluted)	2.03	3.06	2.60	1.74	1.25	0.03
EBITDA	212.31M	277.31M	240.29M	146.16M	111.56M	30.19M
EBIT	149.11M	220.11M	198.52M	117.89M	85.02M	5.01M
Depreciation & Amortization	63.2M	57.21M	41.78M	28.28M	26.53M	25.18M